Skip to main content

Table 1 Demographic characteristics and baseline OAB/sexual scores of participants

From: The effect of mirabegron, used for overactive bladder treatment, on female sexual function: a prospective controlled study

Variable

Group A

Group B

P value

Age (yr)

43.5 (10.0)

43 (10)

0.838

Body weight (kg)

59.0 (14.0)

55.0 (14.0)

0.406

Symptom duration (yr)

4.2 (1.5)

4.2 (3.3)

0.821

Parity

2.0 (2.0)

2.0 (1.0)

0.738

Frequency

11.0 (1.0)

11.0 (2.0)

0.213

Urgency episodes

6.5 (1.0)

7.0 (2.0)

0.303

Nocturia episodes

2.0 (1.0)

2.0 (1.0)

0.227

Incontinence episodes

2.0 (1.0)

2.0 (1.0)

0.287

Incontinence pads

5.0 (2.0)

4.0 (2.0)

0.838

Voided volume (ml)

121.5 (31.0)

117.0 (33.0)

0.725

Desire

3.0 (0.6)

3.0 (1.2)

0.411

Arousal

3.6 (0.6)

3.0 (0.8)

0.281

Lubrication

3.6 (0.9)

3.9 (1.1)

0.214

Orgasm

3.6 (0.4)

3.6 (0.8)

0.253

Satisfaction

3.2 (0.4)

3.2 (0.8)

0.099

Pain

3.2 (0.4)

3.2 (0.8)

0.068

Total Score of Sexual Function

20.0 (2.5)

20.3 (3.8)

0.355